Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lau Johnson Yiu Nam Insider Profile
11 Followers
Lau Johnson Yiu Nam, Director at Akari Therapeutics, holds 0.00 shares in Akari Therapeutics (Ticker: AKTX), holds 297.95K shares in Athenex (Ticker: ATNXQ). Most recently, Lau Johnson Yiu Nam ― shares of Akari Therapeutics on ― for an estimated value of ―.
Lau Johnson Yiu Nam Akari Therapeutics (AKTX)Director
Akari Therapeutics (AKTX)
Director
Ranked #96,307 out of 98,564 Corporate Insiders
Profitable Transactions
7 out of 62 Profitable Transactions
Average Return
-40.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Lau Johnson Yiu Nam does not currently own shares as a corporate insider.
A breakdown of Lau Johnson Yiu Nam's holdings
Insider Roles
Director
Roles that Lau Johnson Yiu Nam holds in companies
Most Profitable Insider Trade
Stock:
Athenex
(ATNXQ)
(ATNXQ)
Rating:Informative Buy
Date:Nov 19, 2018 - Nov 19, 2019
Return:+31.70%
The most profitable trade made by Lau Johnson Yiu Nam
Lau Johnson Yiu Nam's Trading History
Akari Therapeutics
―
Director
―
$0.00
Athenex
May 08, 2023
―
Uninformative Buy
11.40K
$4.47K
List of latest transactions for each holding click on a transaction to see Lau Johnson Yiu Nam's performance on stock
You May Also Like
Lau Johnson Yiu Nam insider profile FAQ
What is the percentage of profitable transactions made by Lau Johnson Yiu Nam?
The percentage of profitable transactions made by Lau Johnson Yiu Nam is 11%.
What is the average return per transaction made by Lau Johnson Yiu Nam?
The average return per transaction made by Lau Johnson Yiu Nam is -40.00%.
What stocks does Lau Johnson Yiu Nam hold?
Lau Johnson Yiu Nam holds: AKTX, ATNXQ stocks.
What was Lau Johnson Yiu Nam’s latest transaction?
Lau Johnson Yiu Nam latest transaction was an Uninformative Buy of ―.
What was Lau Johnson Yiu Nam's most profitable transaction?
Lau Johnson Yiu Nam’s most profitable transaction was an Informative Buy of ATNXQ stock on November 19, 2018. The return on the trade was 31.70%.
What is Lau Johnson Yiu Nam's role in Akari Therapeutics?
Lau Johnson Yiu Nam's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.